DE2508312A1 - Neues verfahren zur herstellung von nucleosiden - Google Patents

Neues verfahren zur herstellung von nucleosiden

Info

Publication number
DE2508312A1
DE2508312A1 DE19752508312 DE2508312A DE2508312A1 DE 2508312 A1 DE2508312 A1 DE 2508312A1 DE 19752508312 DE19752508312 DE 19752508312 DE 2508312 A DE2508312 A DE 2508312A DE 2508312 A1 DE2508312 A1 DE 2508312A1
Authority
DE
Germany
Prior art keywords
organic
alkyl
trimethylsilyl
silylated
general formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE19752508312
Other languages
German (de)
English (en)
Other versions
DE2508312C2 (US07608600-20091027-C00054.png
Inventor
Helmut Dr Vorbrueggen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Priority to DE19752508312 priority Critical patent/DE2508312A1/de
Priority to NL7601625A priority patent/NL7601625A/xx
Priority to SE7602109A priority patent/SE7602109L/xx
Priority to GB767006A priority patent/GB1542442A/en
Priority to LU74411A priority patent/LU74411A1/xx
Priority to US05/660,675 priority patent/US4082911A/en
Priority to CA246,368A priority patent/CA1065315A/en
Priority to JP51019810A priority patent/JPS51125382A/ja
Priority to DK77176A priority patent/DK138900C/da
Priority to FR7605030A priority patent/FR2301536A1/fr
Priority to CH227476A priority patent/CH626093A5/de
Priority to BE164585A priority patent/BE838879A/xx
Publication of DE2508312A1 publication Critical patent/DE2508312A1/de
Application granted granted Critical
Publication of DE2508312C2 publication Critical patent/DE2508312C2/de
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
DE19752508312 1975-02-24 1975-02-24 Neues verfahren zur herstellung von nucleosiden Granted DE2508312A1 (de)

Priority Applications (12)

Application Number Priority Date Filing Date Title
DE19752508312 DE2508312A1 (de) 1975-02-24 1975-02-24 Neues verfahren zur herstellung von nucleosiden
NL7601625A NL7601625A (nl) 1975-02-24 1976-02-18 Werkwijze voor het bereiden van nucleosiden.
GB767006A GB1542442A (en) 1975-02-24 1976-02-23 Process for the manufacture of nucleosides
LU74411A LU74411A1 (US07608600-20091027-C00054.png) 1975-02-24 1976-02-23
US05/660,675 US4082911A (en) 1975-02-24 1976-02-23 Process for the preparation of nucleosides
CA246,368A CA1065315A (en) 1975-02-24 1976-02-23 Process for producing nucleosides
SE7602109A SE7602109L (sv) 1975-02-24 1976-02-23 Nytt forfaringssett for framstellning av nukleosider
DK77176A DK138900C (da) 1975-02-24 1976-02-24 Fremgangsmaade til fremstilling af nucleosider
JP51019810A JPS51125382A (en) 1975-02-24 1976-02-24 Production of nucleotide
FR7605030A FR2301536A1 (fr) 1975-02-24 1976-02-24 Procede de preparation de nucleosides
CH227476A CH626093A5 (US07608600-20091027-C00054.png) 1975-02-24 1976-02-24
BE164585A BE838879A (fr) 1975-02-24 1976-02-24 Nouveau procede de preparation de nucleosides

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19752508312 DE2508312A1 (de) 1975-02-24 1975-02-24 Neues verfahren zur herstellung von nucleosiden

Publications (2)

Publication Number Publication Date
DE2508312A1 true DE2508312A1 (de) 1976-09-02
DE2508312C2 DE2508312C2 (US07608600-20091027-C00054.png) 1987-10-29

Family

ID=5939872

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19752508312 Granted DE2508312A1 (de) 1975-02-24 1975-02-24 Neues verfahren zur herstellung von nucleosiden

Country Status (12)

Country Link
US (1) US4082911A (US07608600-20091027-C00054.png)
JP (1) JPS51125382A (US07608600-20091027-C00054.png)
BE (1) BE838879A (US07608600-20091027-C00054.png)
CA (1) CA1065315A (US07608600-20091027-C00054.png)
CH (1) CH626093A5 (US07608600-20091027-C00054.png)
DE (1) DE2508312A1 (US07608600-20091027-C00054.png)
DK (1) DK138900C (US07608600-20091027-C00054.png)
FR (1) FR2301536A1 (US07608600-20091027-C00054.png)
GB (1) GB1542442A (US07608600-20091027-C00054.png)
LU (1) LU74411A1 (US07608600-20091027-C00054.png)
NL (1) NL7601625A (US07608600-20091027-C00054.png)
SE (1) SE7602109L (US07608600-20091027-C00054.png)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7595390B2 (en) 2003-04-28 2009-09-29 Novartis Ag Industrially scalable nucleoside synthesis
EP2157095A2 (en) 2003-06-30 2010-02-24 Novartis Ag Synthesis of beta-L-2-Deoxy nucleosides
US9968628B2 (en) 2000-05-26 2018-05-15 Idenix Pharmaceuticals Llc Methods and compositions for treating flaviviruses and pestiviruses
US10363265B2 (en) 2000-05-23 2019-07-30 Idenix Pharmaceuticals Llc Methods and compositions for treating hepatitis C virus
US10525072B2 (en) 2002-11-15 2020-01-07 Idenix Pharmaceuticals Llc 2′-branched nucleosides and flaviviridae mutation

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53108986A (en) * 1977-03-02 1978-09-22 Mitsui Toatsu Chem Inc Preparation of nucleosides and nucleotides
DE2721466A1 (de) * 1977-05-12 1978-11-16 Robugen Gmbh Verfahren zur herstellung von 2'-desoxyribofuranosylnucleosiden
US4195176A (en) * 1977-10-11 1980-03-25 Warner-Lambert Company Imidazole compounds, methods for their production and conversion of said compounds into (R)-3-(2-deoxy-β-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazol[4,5-d][1,3]diazepin-8-ol
DE2757365A1 (de) * 1977-12-20 1979-06-21 Schering Ag Neues verfahren zur herstellung von nucleosiden
JPH029511U (US07608600-20091027-C00054.png) * 1988-06-21 1990-01-22
CA2091732C (en) * 1992-07-08 1998-07-21 Anica Markovac A process for the preparation of 2-fluoro-9-(2,3,5-tri-o-benzyl-beta-d-arabinofuranosyl) adenine
JPH07276137A (ja) * 1994-03-31 1995-10-24 Osaka Diamond Ind Co Ltd 切削・研削用工具
DE19513330A1 (de) * 1995-04-03 1996-10-10 Schering Ag Neues Verfahren zur Herstellung von Nucleosiden
US7608600B2 (en) 2002-06-28 2009-10-27 Idenix Pharmaceuticals, Inc. Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
MXPA04012802A (es) 2002-06-28 2005-04-19 Idenix Cayman Ltd Ester 2'-c-metil-3'-o-l-valina de ribofuranosil-citidina para el tratamiento de infecciones por flaviviridae.
US6887855B2 (en) 2003-03-17 2005-05-03 Pharmion Corporation Forms of 5-azacytidine
US7038038B2 (en) * 2003-03-17 2006-05-02 Pharmion Corporation Synthesis of 5-azacytidine
US6943249B2 (en) * 2003-03-17 2005-09-13 Ash Stevens, Inc. Methods for isolating crystalline Form I of 5-azacytidine
AT502635A1 (de) * 2005-11-09 2007-05-15 Saischek Und Partner Meg Neue 1,3-dithioverbindungen, verfahren zu deren herstellung und ihre verwendung
ES2422290T3 (es) 2005-12-23 2013-09-10 Idenix Pharmaceuticals Inc Procedimiento para preparar un producto intermedio sintético para la preparación de nucleósidos ramificados
EP2050757A1 (en) * 2007-10-10 2009-04-22 Cilag AG Method of producing 2' -deoxy-5-azacytidine (Decitabine)
EP2048151A1 (en) 2007-10-10 2009-04-15 Cilag AG Method for producing nucleosides by direct glycosylation of the nucleoside base
EP2299984B1 (en) 2008-05-15 2018-11-28 Celgene Corporation Oral formulations of cytidine analogs and methods of use thereof
EP2321302B1 (en) 2008-08-01 2014-10-29 Dr. Reddy's Laboratories Ltd. Azacitidine process and polymorphs
EP2520581A1 (en) * 2008-08-06 2012-11-07 Sicor, Inc. Method for the determination the purity of 5-Azacytidine
EP2318423B1 (en) * 2008-08-08 2014-05-07 ScinoPharm Taiwan, Ltd. Process for making 5-azacytosine nucleosides and their derivatives
AR076418A1 (es) * 2009-04-27 2011-06-08 Reddys Lab Inc Dr Preparacion de decitabina
MX2013010945A (es) 2011-03-31 2014-03-12 Celgene Internat Sarl Sintesis de 5 - azacitidina.
CN108239128B (zh) * 2016-12-23 2019-03-29 江苏奥赛康药业股份有限公司 β-核苷类化合物的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3354160A (en) * 1965-07-22 1967-11-21 Hoffmann La Roche Tri-lower alkyl-silyl-5-fluoropyrimidines
US3352849A (en) * 1965-10-24 1967-11-14 Merck & Co Inc 6-aza-2'-deoxyuridines
SU452961A3 (ru) * 1969-04-11 1974-12-05 Шеринг Аг. (Фирма) Способ получени пиримидиннуклеозидов
DE2122991C2 (de) * 1971-05-04 1982-06-09 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur Herstellung von Cytosin- und 6-Azacytosinnucleosiden

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DE-Z: Chemische Berichte, Bd. 101, 1968, S. 1095-1114 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10363265B2 (en) 2000-05-23 2019-07-30 Idenix Pharmaceuticals Llc Methods and compositions for treating hepatitis C virus
US10758557B2 (en) 2000-05-23 2020-09-01 Idenix Pharmaceuticals Llc Methods and compositions for treating hepatitis C virus
US9968628B2 (en) 2000-05-26 2018-05-15 Idenix Pharmaceuticals Llc Methods and compositions for treating flaviviruses and pestiviruses
US10525072B2 (en) 2002-11-15 2020-01-07 Idenix Pharmaceuticals Llc 2′-branched nucleosides and flaviviridae mutation
US7595390B2 (en) 2003-04-28 2009-09-29 Novartis Ag Industrially scalable nucleoside synthesis
EP2157095A2 (en) 2003-06-30 2010-02-24 Novartis Ag Synthesis of beta-L-2-Deoxy nucleosides

Also Published As

Publication number Publication date
BE838879A (fr) 1976-08-24
JPS6139318B2 (US07608600-20091027-C00054.png) 1986-09-03
DK77176A (da) 1976-08-25
FR2301536B1 (US07608600-20091027-C00054.png) 1979-07-27
FR2301536A1 (fr) 1976-09-17
GB1542442A (en) 1979-03-21
DK138900C (da) 1979-04-30
CA1065315A (en) 1979-10-30
CH626093A5 (US07608600-20091027-C00054.png) 1981-10-30
JPS51125382A (en) 1976-11-01
US4082911A (en) 1978-04-04
SE7602109L (sv) 1976-08-25
DK138900B (da) 1978-11-13
NL7601625A (nl) 1976-08-26
LU74411A1 (US07608600-20091027-C00054.png) 1976-08-13
DE2508312C2 (US07608600-20091027-C00054.png) 1987-10-29

Similar Documents

Publication Publication Date Title
DE2508312A1 (de) Neues verfahren zur herstellung von nucleosiden
EP0003229B1 (de) Neues Verfahren zur Herstellung von Nucleosiden
DE69533277T2 (de) Dc-89 derivat
DE60026861T2 (de) Purin-derivate
EP0042592A1 (de) N-Heteroaryl-alkylendiamine, Verfahren zu ihrer Herstellung sowie ihre Verwendung
DD284679A5 (de) Verfahren zur herstellung von adenosin 5'-carboamidderivate
EP0135762B1 (de) Steroide
DE3044740C2 (US07608600-20091027-C00054.png)
DE3390162T1 (de) Desoxyuridinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Pharmazeutika
DD255351A5 (de) Verfahren zur herstellung von carbocyclischen purinnucleosiden
DE2912112C2 (de) Antikrebs-Präparat
DE60204859T2 (de) Verfahren zur Herstellung von 2'-Halo-beta-L-arabino-furanosylnucleosiden
EP0255894B1 (de) Pyrimidinderivate, deren Herstellung und Arzneimittel, die diese Derivate enthalten
EP0047328A1 (de) 1H- und 2H-Indazolderivate und diese enthaltendes Arzneimittel
DE3045375A1 (de) Neue substituierte pyrimidin-nukleoside mit antiviraler wirkung, verfahren zu deren herstellung und daraus zubereitete arzneiformen
DD284025A5 (de) Verfahren zur herstellung von imidazo(4,5-b)pyridin-derivaten
DE2505068A1 (de) Imidazo eckige klammer auf 2,1-b eckige klammer zu thiazole
DE3233198A1 (de) (e)-5-(2''-(brom)-vinyl)-uridine, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
EP0614462B1 (de) Neues verfahren zur herstellung von 2-fluorpurin-derivaten
DE2740854A1 (de) Neue substituierte 3-indolacetoxyalkansulfonsaeuresalze, verfahren zu ihrer herstellung und ihre anwendung als arzneimittel
WO2009135455A2 (de) Verfahren zur herstellung von gemcitabin-hydrochorid und zwischenprodukte
DE2208542A1 (de) Synthetische Nucleoside vom Polyoxintyp und Verfahren zur Herstellung von Hexofuranosyluronamidnucleosiden
EP0433218B1 (de) Verfahren zur Herstellung von Aminotriazinderivaten
DE3705794A1 (de) Verfahren zur herstellung von 1-(3-azido-2,3-didesoxy-ss-d- erythropentofuranosyl)pyrimidinen sowie neue zwischenprodukte
CH655934A5 (en) 5-Alkylpyrimidine nucleosides

Legal Events

Date Code Title Description
D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee